Stephanie Wesolowski
Concepts (302)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetus | 40 | 2026 | 800 | 5.690 |
Why?
| | Liver | 29 | 2026 | 1889 | 4.710 |
Why?
| | Sheep | 50 | 2026 | 880 | 4.510 |
Why?
| | Fetal Growth Retardation | 32 | 2025 | 591 | 4.490 |
Why?
| | Glucose | 24 | 2024 | 1033 | 3.690 |
Why?
| | Diet, Western | 12 | 2025 | 86 | 2.870 |
Why?
| | Placental Insufficiency | 17 | 2025 | 126 | 2.660 |
Why?
| | Hypoxia | 8 | 2025 | 1193 | 2.320 |
Why?
| | Pregnancy | 71 | 2026 | 7122 | 2.200 |
Why?
| | Insulin | 31 | 2025 | 2502 | 2.150 |
Why?
| | Amino Acids | 16 | 2026 | 521 | 2.120 |
Why?
| | Liver Cirrhosis | 3 | 2025 | 287 | 2.090 |
Why?
| | Fetal Development | 13 | 2025 | 295 | 1.880 |
Why?
| | Fetal Hypoxia | 4 | 2025 | 56 | 1.750 |
Why?
| | Prenatal Exposure Delayed Effects | 7 | 2025 | 641 | 1.700 |
Why?
| | Maternal Nutritional Physiological Phenomena | 5 | 2025 | 178 | 1.680 |
Why?
| | Gluconeogenesis | 10 | 2026 | 82 | 1.650 |
Why?
| | Maternal-Fetal Exchange | 5 | 2024 | 169 | 1.540 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2023 | 265 | 1.490 |
Why?
| | Muscle, Skeletal | 19 | 2025 | 1788 | 1.490 |
Why?
| | Metformin | 3 | 2024 | 320 | 1.400 |
Why?
| | Adaptation, Physiological | 4 | 2025 | 567 | 1.330 |
Why?
| | Animals | 86 | 2026 | 37948 | 1.280 |
Why?
| | Oxidation-Reduction | 8 | 2025 | 1078 | 1.210 |
Why?
| | Lactic Acid | 5 | 2024 | 303 | 1.170 |
Why?
| | Placenta | 11 | 2025 | 781 | 1.160 |
Why?
| | Insulin Resistance | 11 | 2025 | 1241 | 1.100 |
Why?
| | Pancreas | 7 | 2024 | 341 | 1.000 |
Why?
| | Placental Circulation | 5 | 2025 | 71 | 0.990 |
Why?
| | Hyperinsulinism | 4 | 2020 | 114 | 0.950 |
Why?
| | Glucagon | 7 | 2026 | 114 | 0.850 |
Why?
| | Female | 83 | 2026 | 78304 | 0.810 |
Why?
| | Bile Acids and Salts | 1 | 2025 | 163 | 0.790 |
Why?
| | Leucine | 7 | 2022 | 116 | 0.750 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2025 | 191 | 0.740 |
Why?
| | Glucose Clamp Technique | 4 | 2020 | 199 | 0.730 |
Why?
| | Leukocytes | 1 | 2024 | 294 | 0.720 |
Why?
| | Adipose Tissue | 5 | 2021 | 643 | 0.700 |
Why?
| | Insulin-Secreting Cells | 5 | 2024 | 390 | 0.670 |
Why?
| | Disease Models, Animal | 12 | 2025 | 4539 | 0.640 |
Why?
| | Hypoglycemic Agents | 4 | 2024 | 1388 | 0.640 |
Why?
| | Primates | 5 | 2024 | 133 | 0.630 |
Why?
| | Hepatocytes | 5 | 2024 | 221 | 0.590 |
Why?
| | Islets of Langerhans | 7 | 2024 | 842 | 0.570 |
Why?
| | Insulin-Like Growth Factor I | 6 | 2024 | 317 | 0.550 |
Why?
| | Fetal Blood | 5 | 2024 | 325 | 0.520 |
Why?
| | Blood Glucose | 10 | 2025 | 2326 | 0.510 |
Why?
| | Gestational Age | 8 | 2025 | 980 | 0.510 |
Why?
| | Leptin | 5 | 2016 | 247 | 0.500 |
Why?
| | Pregnancy Complications | 2 | 2019 | 586 | 0.480 |
Why?
| | Oxygen Consumption | 3 | 2025 | 717 | 0.480 |
Why?
| | Lactation | 4 | 2024 | 192 | 0.470 |
Why?
| | Oxygen | 7 | 2023 | 984 | 0.460 |
Why?
| | Energy Metabolism | 2 | 2021 | 927 | 0.400 |
Why?
| | Gene Expression Regulation | 7 | 2025 | 2591 | 0.400 |
Why?
| | Myoblasts | 3 | 2021 | 83 | 0.400 |
Why?
| | Obesity | 7 | 2025 | 3070 | 0.390 |
Why?
| | Mammary Glands, Animal | 3 | 2010 | 128 | 0.390 |
Why?
| | Macaca | 6 | 2025 | 65 | 0.380 |
Why?
| | Lipid Metabolism | 6 | 2024 | 524 | 0.380 |
Why?
| | Pyruvic Acid | 2 | 2024 | 55 | 0.370 |
Why?
| | Uterus | 3 | 2021 | 224 | 0.350 |
Why?
| | Mitochondria | 3 | 2024 | 984 | 0.340 |
Why?
| | Cell Proliferation | 5 | 2024 | 2489 | 0.340 |
Why?
| | Oxidative Stress | 3 | 2025 | 1338 | 0.330 |
Why?
| | RNA, Messenger | 8 | 2016 | 2815 | 0.330 |
Why?
| | Diet, High-Fat | 3 | 2023 | 261 | 0.320 |
Why?
| | Receptors, Leptin | 3 | 2008 | 25 | 0.300 |
Why?
| | Infusions, Intravenous | 6 | 2021 | 422 | 0.300 |
Why?
| | Cattle | 5 | 2016 | 975 | 0.290 |
Why?
| | Glucagon-Secreting Cells | 2 | 2024 | 25 | 0.260 |
Why?
| | Up-Regulation | 4 | 2017 | 848 | 0.250 |
Why?
| | Macaca mulatta | 2 | 2024 | 186 | 0.240 |
Why?
| | Uterine Artery | 2 | 2024 | 74 | 0.240 |
Why?
| | Gene Expression Profiling | 3 | 2019 | 1766 | 0.240 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2025 | 23 | 0.230 |
Why?
| | Hypoglycemia | 3 | 2014 | 479 | 0.230 |
Why?
| | Citrate (si)-Synthase | 2 | 2024 | 53 | 0.230 |
Why?
| | Muscle Development | 3 | 2021 | 113 | 0.230 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2021 | 214 | 0.220 |
Why?
| | Sheep, Domestic | 3 | 2019 | 34 | 0.220 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2024 | 2573 | 0.220 |
Why?
| | Linoleic Acids, Conjugated | 1 | 2014 | 7 | 0.220 |
Why?
| | Signal Transduction | 7 | 2024 | 5185 | 0.220 |
Why?
| | Mammals | 2 | 2023 | 296 | 0.210 |
Why?
| | Capillaries | 1 | 2025 | 118 | 0.210 |
Why?
| | Fatty Acids | 2 | 2023 | 454 | 0.210 |
Why?
| | Stilbenes | 1 | 2014 | 33 | 0.200 |
Why?
| | Hindlimb | 3 | 2021 | 131 | 0.200 |
Why?
| | Milk | 1 | 2014 | 119 | 0.200 |
Why?
| | Glycine | 2 | 2023 | 186 | 0.200 |
Why?
| | Fetal Heart | 1 | 2024 | 56 | 0.200 |
Why?
| | Mitochondria, Heart | 1 | 2024 | 101 | 0.200 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.200 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2025 | 204 | 0.190 |
Why?
| | Macrophages | 3 | 2020 | 1496 | 0.190 |
Why?
| | Muscle Proteins | 3 | 2022 | 240 | 0.190 |
Why?
| | Immunophenotyping | 1 | 2024 | 318 | 0.190 |
Why?
| | Blotting, Western | 3 | 2019 | 1161 | 0.190 |
Why?
| | Glutamine | 1 | 2023 | 108 | 0.190 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 59 | 0.180 |
Why?
| | Serine | 1 | 2023 | 142 | 0.180 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 14 | 0.180 |
Why?
| | Hypothalamus | 1 | 2003 | 160 | 0.180 |
Why?
| | Gene Expression | 4 | 2023 | 1476 | 0.180 |
Why?
| | Body Temperature Regulation | 1 | 2003 | 107 | 0.180 |
Why?
| | Dietary Fats | 1 | 2014 | 308 | 0.180 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 12 | 0.180 |
Why?
| | Sympathetic Nervous System | 1 | 2012 | 180 | 0.170 |
Why?
| | Quantitative Trait Loci | 1 | 2004 | 374 | 0.170 |
Why?
| | Malnutrition | 1 | 2012 | 86 | 0.170 |
Why?
| | Bone Marrow | 1 | 2023 | 306 | 0.170 |
Why?
| | Fatty Liver | 1 | 2014 | 250 | 0.170 |
Why?
| | Swine | 1 | 2004 | 828 | 0.170 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2019 | 906 | 0.170 |
Why?
| | Triglycerides | 2 | 2018 | 517 | 0.160 |
Why?
| | Phenotype | 3 | 2023 | 3147 | 0.160 |
Why?
| | Mitochondrial Diseases | 1 | 2021 | 92 | 0.160 |
Why?
| | Fibrosis | 1 | 2023 | 547 | 0.160 |
Why?
| | Mitochondria, Liver | 1 | 2020 | 70 | 0.160 |
Why?
| | Maternal Exposure | 1 | 2021 | 185 | 0.150 |
Why?
| | Altitude | 1 | 2024 | 473 | 0.150 |
Why?
| | Chorioamnionitis | 1 | 2020 | 49 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2019 | 973 | 0.150 |
Why?
| | Sexual Maturation | 2 | 2008 | 48 | 0.150 |
Why?
| | Hematopoietic Stem Cells | 1 | 2023 | 419 | 0.150 |
Why?
| | Organ Size | 4 | 2021 | 461 | 0.150 |
Why?
| | Male | 15 | 2025 | 72431 | 0.150 |
Why?
| | Glycolysis | 1 | 2021 | 341 | 0.150 |
Why?
| | Acidosis | 1 | 2020 | 105 | 0.150 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 20 | 0.150 |
Why?
| | Antioxidants | 1 | 2023 | 546 | 0.150 |
Why?
| | Humans | 18 | 2025 | 144671 | 0.150 |
Why?
| | Drug Administration Schedule | 4 | 2021 | 779 | 0.140 |
Why?
| | Protein Biosynthesis | 2 | 2017 | 455 | 0.140 |
Why?
| | STAT3 Transcription Factor | 1 | 2010 | 205 | 0.140 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2016 | 29 | 0.140 |
Why?
| | Genomics | 1 | 2004 | 831 | 0.140 |
Why?
| | Embryo, Mammalian | 1 | 2019 | 232 | 0.140 |
Why?
| | Cell Division | 2 | 2017 | 753 | 0.140 |
Why?
| | Stem Cells | 1 | 2022 | 621 | 0.140 |
Why?
| | Cytokines | 3 | 2014 | 2045 | 0.130 |
Why?
| | Anemia | 2 | 2017 | 189 | 0.130 |
Why?
| | Estradiol | 2 | 2010 | 507 | 0.130 |
Why?
| | Metabolic Diseases | 1 | 2018 | 114 | 0.130 |
Why?
| | Glucose Intolerance | 1 | 2018 | 142 | 0.130 |
Why?
| | Oxidative Phosphorylation | 3 | 2024 | 209 | 0.130 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 145 | 0.130 |
Why?
| | Adiponectin | 1 | 2018 | 240 | 0.120 |
Why?
| | Hydrocortisone | 4 | 2020 | 297 | 0.120 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2016 | 55 | 0.120 |
Why?
| | Models, Animal | 3 | 2024 | 393 | 0.120 |
Why?
| | Proteins | 1 | 2012 | 1016 | 0.120 |
Why?
| | Random Allocation | 3 | 2012 | 366 | 0.120 |
Why?
| | Lactates | 1 | 2015 | 83 | 0.110 |
Why?
| | Lower Extremity | 1 | 2019 | 440 | 0.110 |
Why?
| | Glucose-6-Phosphatase | 3 | 2016 | 31 | 0.110 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 35 | 0.110 |
Why?
| | Hyperglycemia | 1 | 2018 | 374 | 0.100 |
Why?
| | Transcription Factors | 2 | 2014 | 1726 | 0.100 |
Why?
| | Growth Hormone | 3 | 2016 | 91 | 0.100 |
Why?
| | Blotting, Northern | 2 | 2004 | 203 | 0.100 |
Why?
| | Epithelial Cells | 2 | 2008 | 1106 | 0.100 |
Why?
| | Infant, Newborn | 3 | 2024 | 6399 | 0.090 |
Why?
| | Inflammation | 2 | 2020 | 2870 | 0.090 |
Why?
| | Animal Feed | 2 | 2021 | 55 | 0.090 |
Why?
| | Breast Feeding | 1 | 2016 | 444 | 0.090 |
Why?
| | Chromosome Mapping | 2 | 2004 | 507 | 0.090 |
Why?
| | Transcriptome | 1 | 2019 | 1036 | 0.090 |
Why?
| | Regional Blood Flow | 2 | 2024 | 513 | 0.090 |
Why?
| | Epigenesis, Genetic | 1 | 2016 | 669 | 0.090 |
Why?
| | Fetal Weight | 2 | 2021 | 53 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 4261 | 0.080 |
Why?
| | Mice | 6 | 2022 | 18261 | 0.080 |
Why?
| | Polymerase Chain Reaction | 2 | 2004 | 1047 | 0.080 |
Why?
| | Glycogen | 2 | 2016 | 55 | 0.080 |
Why?
| | Mice, Obese | 2 | 2018 | 66 | 0.080 |
Why?
| | Phosphorylation | 3 | 2020 | 1704 | 0.070 |
Why?
| | Tissue Distribution | 2 | 2012 | 335 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2020 | 435 | 0.070 |
Why?
| | Dietary Supplements | 2 | 2014 | 575 | 0.070 |
Why?
| | Inflammation Mediators | 2 | 2012 | 503 | 0.070 |
Why?
| | Gastrointestinal Microbiome | 1 | 2016 | 771 | 0.070 |
Why?
| | Down-Regulation | 2 | 2017 | 616 | 0.070 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2012 | 39 | 0.070 |
Why?
| | Animal Nutritional Physiological Phenomena | 2 | 2008 | 14 | 0.060 |
Why?
| | Liver Glycogen | 2 | 2016 | 16 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 2019 | 0.060 |
Why?
| | Biological Transport | 2 | 2020 | 418 | 0.060 |
Why?
| | Immunity, Innate | 2 | 2023 | 843 | 0.060 |
Why?
| | Lactalbumin | 1 | 2014 | 2 | 0.050 |
Why?
| | Receptors, Glucagon | 1 | 2025 | 26 | 0.050 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.050 |
Why?
| | Milk Proteins | 1 | 2014 | 33 | 0.050 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2014 | 56 | 0.050 |
Why?
| | RNA | 2 | 2008 | 926 | 0.050 |
Why?
| | Lipogenesis | 1 | 2014 | 62 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 105 | 0.050 |
Why?
| | Contraindications | 1 | 2014 | 90 | 0.050 |
Why?
| | Amniotic Fluid | 1 | 2024 | 79 | 0.050 |
Why?
| | Gene Order | 1 | 2003 | 28 | 0.050 |
Why?
| | Expressed Sequence Tags | 1 | 2003 | 43 | 0.050 |
Why?
| | Animals, Inbred Strains | 1 | 2012 | 6 | 0.050 |
Why?
| | Computer Systems | 1 | 2003 | 55 | 0.050 |
Why?
| | Receptors, Neuropeptide Y | 1 | 2012 | 1 | 0.050 |
Why?
| | Sympathetic Fibers, Postganglionic | 1 | 2012 | 4 | 0.050 |
Why?
| | Neuropeptide Y | 1 | 2012 | 10 | 0.050 |
Why?
| | Ceramides | 1 | 2023 | 117 | 0.050 |
Why?
| | Macrophage Activation | 1 | 2014 | 186 | 0.050 |
Why?
| | Glucose Transporter Type 2 | 1 | 2012 | 16 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2014 | 360 | 0.050 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2012 | 72 | 0.050 |
Why?
| | Apoptosis | 2 | 2019 | 2397 | 0.050 |
Why?
| | Electrolytes | 1 | 2012 | 54 | 0.050 |
Why?
| | Cell Size | 1 | 2012 | 92 | 0.050 |
Why?
| | Hepatitis | 1 | 2012 | 43 | 0.050 |
Why?
| | Mice, Inbred Strains | 1 | 2003 | 396 | 0.050 |
Why?
| | Solutions | 1 | 2012 | 166 | 0.050 |
Why?
| | Acid-Base Equilibrium | 1 | 2012 | 24 | 0.050 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 153 | 0.040 |
Why?
| | Risk Factors | 1 | 2016 | 10796 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 2012 | 81 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2016 | 2350 | 0.040 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 116 | 0.040 |
Why?
| | Mice, SCID | 1 | 2022 | 368 | 0.040 |
Why?
| | Carbon Isotopes | 1 | 2012 | 144 | 0.040 |
Why?
| | Proteolysis | 1 | 2012 | 170 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 203 | 0.040 |
Why?
| | Hormones | 1 | 2012 | 133 | 0.040 |
Why?
| | Arginine | 1 | 2012 | 238 | 0.040 |
Why?
| | Infusion Pumps | 1 | 2021 | 33 | 0.040 |
Why?
| | Time Factors | 2 | 2012 | 7140 | 0.040 |
Why?
| | Birth Weight | 1 | 2024 | 506 | 0.040 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 339 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 751 | 0.040 |
Why?
| | Fetal Macrosomia | 1 | 2021 | 62 | 0.040 |
Why?
| | Placentation | 1 | 2021 | 52 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2022 | 610 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5967 | 0.040 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 66 | 0.040 |
Why?
| | Carbon Dioxide | 1 | 2012 | 239 | 0.040 |
Why?
| | Receptors, Nicotinic | 1 | 2012 | 328 | 0.040 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 77 | 0.040 |
Why?
| | Drug Synergism | 1 | 2020 | 352 | 0.040 |
Why?
| | Pregnancy, Animal | 1 | 2019 | 51 | 0.040 |
Why?
| | Norepinephrine | 1 | 2020 | 196 | 0.040 |
Why?
| | Body Weight | 1 | 2004 | 968 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2014 | 741 | 0.040 |
Why?
| | Fetal Diseases | 1 | 2021 | 193 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2003 | 2909 | 0.030 |
Why?
| | Alanine | 1 | 2019 | 170 | 0.030 |
Why?
| | Kinetics | 1 | 2012 | 1603 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 22 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2008 | 138 | 0.030 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2008 | 85 | 0.030 |
Why?
| | Cell Count | 1 | 2018 | 320 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2008 | 112 | 0.030 |
Why?
| | Dairying | 1 | 2007 | 12 | 0.030 |
Why?
| | Receptor, Insulin | 1 | 2007 | 93 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2004 | 1468 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2007 | 168 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2008 | 126 | 0.030 |
Why?
| | Diabetes, Gestational | 1 | 2021 | 303 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 2007 | 535 | 0.030 |
Why?
| | Ovariectomy | 1 | 2007 | 163 | 0.030 |
Why?
| | Apolipoproteins B | 1 | 2016 | 47 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2020 | 854 | 0.030 |
Why?
| | Temperature | 1 | 2019 | 680 | 0.030 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2006 | 20 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1495 | 0.030 |
Why?
| | Diet | 1 | 2014 | 1270 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 890 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2008 | 390 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2016 | 92 | 0.030 |
Why?
| | Thyroid Hormones | 1 | 2016 | 68 | 0.030 |
Why?
| | Exons | 1 | 2016 | 362 | 0.030 |
Why?
| | Luteinizing Hormone | 1 | 2016 | 190 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2008 | 475 | 0.030 |
Why?
| | Carbon Radioisotopes | 1 | 2014 | 29 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2010 | 2184 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2016 | 369 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1046 | 0.030 |
Why?
| | Genome | 1 | 2016 | 305 | 0.030 |
Why?
| | Receptors, Cell Surface | 1 | 2006 | 370 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2008 | 770 | 0.030 |
Why?
| | Eating | 1 | 2016 | 388 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2008 | 1207 | 0.020 |
Why?
| | Blood Transfusion | 1 | 2016 | 405 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2014 | 254 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2010 | 4110 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1847 | 0.020 |
Why?
| | Genetic Variation | 1 | 2016 | 985 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1810 | 0.020 |
Why?
| | Cell Line | 1 | 2006 | 2821 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 750 | 0.020 |
Why?
| | Adult | 2 | 2024 | 40489 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 26 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2137 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 43 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 14122 | 0.020 |
Why?
| | Algorithms | 1 | 2014 | 1844 | 0.020 |
Why?
| | Adolescent | 1 | 2023 | 22409 | 0.010 |
Why?
|
|
Wesolowski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|